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ABSTRACT 
Cardiovascular diseases are one of the leading causes of mortality. A common denominator 
across most of the cardiovascular diseases like diabetic cardiomyopathy, hypertrophic 
cardiomyopathy, myocardial infarction and dilated cardiomyopathy is the pathological 
remodelling of heart leading to fibrosis. Cardiac fibrosis is characterized by the excessive 
production and deposition of extracellular matrix components due to unwarranted proliferation 
of fibroblasts. Under normal conditions, following cardiac remodelling, myofibroblasts 
undergo programmed cell death. However, this does not happen under pathological conditions 
ultimately leading to fibrosis. Although the molecular events and signalling pathways that 
contribute to the development of cardiac fibrosis is well established, there are limited studies 
which try to understand the mechanisms by which fibroblasts persist and resist programmed 
cell death. Here we demonstrate that SIRT6, one of the members of sirtuin family of histone 
deacetylases, plays an important role in regulating myofibroblast cell death. 
When we analysed the mice hearts and isolated fibroblasts deficient in SIRT6, we observed 
increased expression of myofibroblast markers, suggesting that SIRT6 deficient hearts might 
have a high proportion of resident myofibroblasts. Also, when SIRT6 deficient fibroblasts were 
subjected to genotoxic stress, they showed reduced cell death and impaired mitochondrial to 
nuclear AIF translocation as compared to WT controls. An important regulator of AIF mediated 
cell death is the protein PARP-1. When we checked the expression levels of this protein under 
SIRT6 deficient conditions, it was found to be low. PARP-1 was also found to degrade faster 
under SIRT6 deficient conditions. Further qPCR analysis revealed that the transcript levels of 
PARP-1 were unaffected by SIRT6 suggesting that the regulation might not be at the 
transcriptional level. When we studied the acetylation of PARP-1 under SIRT6 deficient 
conditions we found the protein to be hypo-acetylated indicating a more complex mechanism 
of regulation. 
 
